A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Eli Lilly and Company
Study ID
NCT07641504
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chronic Pain
  • Low Back Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • LY4065967 — DRUG
    Administered orally.
  • Placebo — DRUG
    Administered orally

Study Details

The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.

Key Dates

Start date
Jul 31, 2026
Status verified
Jan 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: LY4065967
    LY4065967 administered orally.
  • Placebo Comparator: Placebo
    Placebo administered orally.

Primary Outcome Measure

Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) [ Time Frame: Baseline, Week 8 ]

Central Contacts

  • Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
    1-317-615-4559
    [email protected]
  • Physicians interested in becoming principal investigators please contact
    [email protected]

Locations (36)

FacilityCityStateZIPSite coordinators
Central Research AssociatesBirminghamAlabama35205
David DeAtkine (PRINCIPAL_INVESTIGATOR)
Arizona Research CenterPhoenixArizona85053
Louise Taber MD (PRINCIPAL_INVESTIGATOR)
Central Phoenix Medical ClinicPhoenixArizona85020
Elysa Shaw (PRINCIPAL_INVESTIGATOR)
Desert Oasis Healthcare Medical GroupPalm SpringsCalifornia92262
Michael Jardula (PRINCIPAL_INVESTIGATOR)
Artemis Institute for Clinical ResearchRiversideCalifornia92503
Jack Vu (PRINCIPAL_INVESTIGATOR)
Artemis Institute for Clinical ResearchSan DiegoCalifornia92103
Stacey Layle (PRINCIPAL_INVESTIGATOR)
CMR of Greater New HavenHamdenConnecticut06517
Joseph Soufer (PRINCIPAL_INVESTIGATOR)
Bradenton Research Center, Inc.BradentonFlorida34205
Eric Folkens (PRINCIPAL_INVESTIGATOR)
Accel Research Sites - DeLand Clinical Research UnitDeLandFlorida32720
Bruce Rankin (PRINCIPAL_INVESTIGATOR)
K2 MEDICAL Research THE VILLAGESLady LakeFlorida32159
Craig Curtis (PRINCIPAL_INVESTIGATOR)
K2 Medical Research ORLANDOMaitlandFlorida32751
Brandon Lenox (PRINCIPAL_INVESTIGATOR)
Merritt Island Medical Research, LLCMerritt IslandFlorida32952
David Kirk (PRINCIPAL_INVESTIGATOR)
New Horizon Research CenterMiamiFlorida33165
Lazaro Nunez (PRINCIPAL_INVESTIGATOR)
Suncoast Research GroupMiamiFlorida33135
Mark Kutner (PRINCIPAL_INVESTIGATOR)
Suncoast Clinical Research, Inc.New Port RicheyFlorida34652
Cathy Barnes (PRINCIPAL_INVESTIGATOR)
Renstar Medical ResearchOcalaFlorida34470
David Oliver (PRINCIPAL_INVESTIGATOR)
Precision Clinical ResearchSunriseFlorida33351
Richard Linn (PRINCIPAL_INVESTIGATOR)
Charter Research - Lady LakeThe VillagesFlorida32162
Stephen Miller (PRINCIPAL_INVESTIGATOR)
Conquest ResearchWinter ParkFlorida32789
Anand Patel (PRINCIPAL_INVESTIGATOR)
North Georgia Clinical ResearchWoodstockGeorgia30189
6784945735
Bram Wieskopf (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Thomas Schnitzer (PRINCIPAL_INVESTIGATOR)
DelRicht ResearchNew OrleansLouisiana70115
Patrick Dennis (PRINCIPAL_INVESTIGATOR)
Lucida Clinical TrialsNew BedfordMassachusetts02740
David Shih (PRINCIPAL_INVESTIGATOR)
MedVadis Research CorporationWalthamMassachusetts02451
David DiBenedetto (PRINCIPAL_INVESTIGATOR)
Great Lakes Research Group, Inc.Bay CityMichigan48706
Jeffrey Potts (PRINCIPAL_INVESTIGATOR)
StudyMetrix ResearchCity of Saint PetersMissouri63303
Timothy Smith (PRINCIPAL_INVESTIGATOR)
Clinvest Research LLCSpringfieldMissouri65807
Ralph Duda (PRINCIPAL_INVESTIGATOR)
Rochester Clinical Research, LLCRochesterNew York14609
Patrick Connors (PRINCIPAL_INVESTIGATOR)
Lillestol ResearchFargoNorth Dakota58104
Michael Lillestol (PRINCIPAL_INVESTIGATOR)
META Medical Research InstituteDaytonOhio45432
Priyesh Mehta (PRINCIPAL_INVESTIGATOR)
DelRicht ResearchTulsaOklahoma74133
Melita Tate (PRINCIPAL_INVESTIGATOR)
Altoona Center For Clinical ResearchDuncansvillePennsylvania16635
Alan Kivitz (PRINCIPAL_INVESTIGATOR)
FutureSearch Trials of NeurologyAustinTexas78731
John Hudson (PRINCIPAL_INVESTIGATOR)
Re:Cognition Health - Fort WorthFort WorthTexas76104
Claudia Perez (PRINCIPAL_INVESTIGATOR)
Northwest Clinical Research CenterBellevueWashington98007
Arifulla Khan, MD (PRINCIPAL_INVESTIGATOR)
Rainier Clinical Research CenterRentonWashington98057
Sheryl Marks (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

By research site
Central Research Associates· Birmingham, ALArizona Research Center· Phoenix, AZCentral Phoenix Medical Clinic· Phoenix, AZDesert Oasis Healthcare Medical Group· Palm Springs, CAArtemis Institute for Clinical Research· Riverside, CAArtemis Institute for Clinical Research· San Diego, CA

Related Studies